210 related articles for article (PubMed ID: 37469401)
41. A case of advanced HCC treated with lenvatinib after hepatic arterial infusion chemotherapy combined with radiation therapy treatment for portal vein tumor thrombosis in the main trunk.
Kosaka Y; Kawaoka T; Aikata H; Suehiro Y; Yamaoka K; Ando Y; Namba M; Takeuchi Y; Fujii Y; Uchikawa S; Kodama K; Oya K; Morio K; Fujino H; Nakahara T; Murakami E; Yamauchi M; Tsuge M; Hiramatsu A; Imamura M; Baba Y; Awai K; Kimura T; Nagata Y; Chayama K
Clin J Gastroenterol; 2020 Oct; 13(5):839-843. PubMed ID: 31974811
[TBL] [Abstract][Full Text] [Related]
42. [A case of curative resection for advanced hepatocellular carcinoma with portal vein tumor thrombus after hepatic arterial infusion chemotherapy].
Ishizaki M; Kaibori M; Matsui K; Nakatake R; Matsushima H; Sakaguchi T; Kwon AH
Gan To Kagaku Ryoho; 2012 Nov; 39(12):1991-3. PubMed ID: 23267953
[TBL] [Abstract][Full Text] [Related]
43. Case Report and Literature Review of Multi-drugs Synergy and Targeted Comprehensive Treatment in Advanced Hepatocellular Carcinoma.
Lu G; Ou L; Cao M; Hu M
Curr Cancer Drug Targets; 2024; 24(3):368-374. PubMed ID: 37533242
[TBL] [Abstract][Full Text] [Related]
44. Transarterial chemoembolization with hepatic arterial infusion chemotherapy plus S-1 for hepatocellular carcinoma.
Guo JH; Liu SX; Gao S; Kou FX; Zhang X; Wu D; Li XT; Chen H; Wang XD; Liu P; Zhang PJ; Xu HF; Cao G; Zhu LZ; Yang RJ; Zhu X
World J Gastroenterol; 2020 Jul; 26(27):3975-3988. PubMed ID: 32774071
[TBL] [Abstract][Full Text] [Related]
45. Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status.
Kodama K; Kawaoka T; Aikata H; Uchikawa S; Inagaki Y; Hatooka M; Morio K; Nakahara T; Murakami E; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Masaki K; Honda Y; Mori N; Takaki S; Tsuji K; Kohno H; Kohno H; Moriya T; Nonaka M; Hyogo H; Aisaka Y; Chayama K
J Gastroenterol Hepatol; 2018 Oct; 33(10):1780-1786. PubMed ID: 29645345
[TBL] [Abstract][Full Text] [Related]
46. Unusual Techniques for Preserving Surgical and Oncologic Safety in Hepatectomy of Advanced Adrenal Malignancy with Vena Cava and Liver Invasion.
Lee JM; Lee KW; Hong SK; Yoon KC; Cho JH; Yi NJ; Suh KS
Ann Surg Oncol; 2018 Oct; 25(11):3324-3325. PubMed ID: 30019302
[TBL] [Abstract][Full Text] [Related]
47. Criteria for identifying potentially resectable patients with initially oncologically unresectable hepatocellular carcinoma before treatment with lenvatinib plus an anti-PD-1 antibody.
Xu B; Zhu XD; Shen YH; Zhu JJ; Liu J; Li ML; Tang PW; Zhou J; Fan J; Sun HC; Huang C
Front Immunol; 2022; 13():1016736. PubMed ID: 36505445
[TBL] [Abstract][Full Text] [Related]
48. Incidental tumor necrosis caused by the interventional alteration of hepatic arterial flow in patients with advanced hepatocellular carcinoma.
Suzuki E; Ooka Y; Chiba T; Kobayashi K; Kanogawa N; Motoyama T; Saito T; Ogasawara S; Tawada A; Yokosuka O
Clin J Gastroenterol; 2015 Feb; 8(1):41-6. PubMed ID: 25481841
[TBL] [Abstract][Full Text] [Related]
49. Association of transarterial chemoembolization with survival in patients with unresectable hepatocellular carcinoma.
Wang P; Sheng L; Wang G; Wang H; Huang X; Yan X; Yang X; Pei R
Mol Clin Oncol; 2014 Mar; 2(2):203-206. PubMed ID: 24649333
[TBL] [Abstract][Full Text] [Related]
50. Hepatic Arterial Infusion Chemotherapy Using Oxaliplatin Plus 5-Fluorouracil Versus Transarterial Chemoembolization/Embolization for the Treatment of Advanced Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis.
Hu J; Bao Q; Cao G; Zhu X; Yang R; Ji X; Xu L; Zheng K; Li W; Xing B; Wang X
Cardiovasc Intervent Radiol; 2020 Jul; 43(7):996-1005. PubMed ID: 31974744
[TBL] [Abstract][Full Text] [Related]
51. Efficacy and safety of hepatic artery infusion chemotherapy combined with tyrosine kinase inhibitors plus programmed death-1 inhibitors for hepatocellular carcinoma refractory to transarterial chemoembolization.
Lin LW; Ke K; Yan LY; Chen R; Huang JY
Front Oncol; 2023; 13():1178428. PubMed ID: 37207144
[TBL] [Abstract][Full Text] [Related]
52. Hypothetical hypoxia-driven rapid disease progression in hepatocellular carcinoma post transarterial chemoembolization: A case report.
Yeo KF; Ker A; Kao PE; Wang CC
World J Clin Cases; 2023 Jul; 11(19):4664-4669. PubMed ID: 37469743
[TBL] [Abstract][Full Text] [Related]
53. Analysis of Patient Outcome after Non-curative Resection for Hepatocellular Carcinoma Using Nationwide Survey Data in Japan.
Aoki T; Kubota K; Kubo S; Eguchi S; Izumi N; Kokudo N; Sakamoto M; Shiina S; Takayama T; Nakashima O; Matsuyama Y; Murakami T; Kudo M
World J Surg; 2021 Feb; 45(2):607-614. PubMed ID: 33104834
[TBL] [Abstract][Full Text] [Related]
54. Achieving complete remission in metastatic hepatocellular carcinoma with sintilimab plus sorafenib therapy followed by hepatic resection: a case report.
Cui K; Li Z; Zhong J; Shi X; Zhao L; Li H; Ma Y
Front Oncol; 2024; 14():1355798. PubMed ID: 38380371
[TBL] [Abstract][Full Text] [Related]
55. [Survival benefit with intraarterial techniques in hepatocellular carcinoma].
Sangro B
Gastroenterol Hepatol; 2014 Jul; 37 Suppl 2():95-101. PubMed ID: 25087719
[TBL] [Abstract][Full Text] [Related]
56. Multi-disciplinary Concurrent Management of Recurrent Hepatocellular Therapy is Superior to Sequential Therapy.
Fields TD; Philips P; Scoggins CR; Tatum C; Kelly L; McMasters KM; Martin RCG
World J Surg; 2017 May; 41(5):1331-1339. PubMed ID: 27905019
[TBL] [Abstract][Full Text] [Related]
57. Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial.
Li QJ; He MK; Chen HW; Fang WQ; Zhou YM; Xu L; Wei W; Zhang YJ; Guo Y; Guo RP; Chen MS; Shi M
J Clin Oncol; 2022 Jan; 40(2):150-160. PubMed ID: 34648352
[TBL] [Abstract][Full Text] [Related]
58. Complete response by patients with advanced hepatocellular carcinoma after combination immune/targeted therapy and transarterial chemoembolization: two case reports and literature review.
Nong X; Zhang YM; Liang JC; Xie JL; Zhang ZM
Transl Cancer Res; 2022 Aug; 11(8):2973-2984. PubMed ID: 36093545
[TBL] [Abstract][Full Text] [Related]
59. Technical feasibility and safety of laparoscopic right hepatectomy for hepatocellular carcinoma following sequential TACE-PVE: a comparative study.
Goumard C; Komatsu S; Brustia R; Fartoux L; Soubrane O; Scatton O
Surg Endosc; 2017 May; 31(5):2340-2349. PubMed ID: 27655376
[TBL] [Abstract][Full Text] [Related]
60. Hepatic Artery Infusion Chemotherapy Using Fluorouracil, Leucovorin, and Oxaliplatin versus Transarterial Chemoembolization as Initial Treatment for Locally Advanced Hepatocellular Carcinoma: A Propensity Score-Matching Analysis.
Li S; Lyu N; Han X; Li J; Lai J; He M; Deng H; Shi M; Wang H; Zhao M
J Vasc Interv Radiol; 2021 Sep; 32(9):1267-1276.e1. PubMed ID: 34166806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
